Thomas H. Rushmore

9.2k total citations · 1 hit paper
68 papers, 6.9k citations indexed

About

Thomas H. Rushmore is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas H. Rushmore has authored 68 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 33 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Thomas H. Rushmore's work include Pharmacogenetics and Drug Metabolism (36 papers), Glutathione Transferases and Polymorphisms (15 papers) and Drug Transport and Resistance Mechanisms (14 papers). Thomas H. Rushmore is often cited by papers focused on Pharmacogenetics and Drug Metabolism (36 papers), Glutathione Transferases and Polymorphisms (15 papers) and Drug Transport and Resistance Mechanisms (14 papers). Thomas H. Rushmore collaborates with scholars based in United States, Canada and Japan. Thomas H. Rushmore's co-authors include C.B. Pickett, Magang Shou, K. Eric Paulson, Mei Qin, David Gerhold, C. Thomas Caskey, Mark Abramovitz, Yves Boie, Kathleen M. Metters and Emmanuel Farber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Thomas H. Rushmore

68 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity

1991 1.2k citations Thomas H. Rushmore et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas H. Rushmore United States	40	3.8k	2.0k	1.1k	756	664	68	6.9k
Russell A. Prough United States	49	2.9k 0.8×	2.5k 1.2×	1.1k 1.0×	476 0.6×	1.1k 1.7×	199	7.7k
Colin J. Henderson United Kingdom	45	4.6k 1.2×	2.4k 1.2×	1.7k 1.5×	332 0.4×	567 0.9×	166	8.6k
Takashi Iyanagi Japan	39	3.0k 0.8×	2.2k 1.1×	1.2k 1.0×	338 0.4×	444 0.7×	85	6.2k
Emanuele Albano Italy	62	3.2k 0.8×	2.1k 1.0×	721 0.6×	344 0.5×	1.3k 1.9×	227	11.9k
Jan N. M. Commandeur Netherlands	39	2.8k 0.7×	2.4k 1.2×	906 0.8×	411 0.5×	589 0.9×	203	6.7k
Gerard J. Mulder Netherlands	41	2.5k 0.6×	1.4k 0.7×	1.0k 0.9×	412 0.5×	666 1.0×	179	5.1k
Hannu Raunio Finland	51	3.0k 0.8×	4.3k 2.2×	2.2k 1.9×	657 0.9×	794 1.2×	168	8.6k
Michael T. Murray Australia	44	2.0k 0.5×	2.4k 1.2×	1.4k 1.3×	530 0.7×	771 1.2×	243	6.3k
Yoshihiko Funae Japan	49	2.2k 0.6×	3.7k 1.8×	1.6k 1.5×	788 1.0×	1.3k 2.0×	214	7.2k
Dominique Pessayre France	69	4.2k 1.1×	5.0k 2.5×	2.1k 1.9×	857 1.1×	822 1.2×	248	14.6k

Countries citing papers authored by Thomas H. Rushmore

Since Specialization

Citations

This map shows the geographic impact of Thomas H. Rushmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Rushmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Rushmore more than expected).

Fields of papers citing papers by Thomas H. Rushmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Rushmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Rushmore. The network helps show where Thomas H. Rushmore may publish in the future.

Co-authorship network of co-authors of Thomas H. Rushmore

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Rushmore. A scholar is included among the top collaborators of Thomas H. Rushmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Rushmore. Thomas H. Rushmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Xia, Bin Zhang, Cliona Molony, et al.. (2010). Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Research. 20(8). 1020–1036. 207 indexed citations

Jin, Bo, Sheila Breidinger, Steven D. Young, et al.. (2009). Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms. Clinical Pharmacology & Therapeutics. 85(6). 623–627. 76 indexed citations

Slatter, J. Greg, Ian E. Templeton, John C. Castle, et al.. (2006). Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome. Xenobiotica. 36(10-11). 938–962. 26 indexed citations

Lü, Ping, Suresh B. Singh, Brian Carr, et al.. (2005). Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12. Journal of Pharmacology and Experimental Therapeutics. 313(2). 518–528. 29 indexed citations

Gibson, Christopher R., Charles C. Lin, Rominder Singh, et al.. (2005). INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY. Drug Metabolism and Disposition. 33(7). 1044–1051. 5 indexed citations

Chen, Qing, Eugene Tan, John R. Strauss, et al.. (2004). Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection. Journal of Pharmacology and Experimental Therapeutics. 311(1). 307–314. 2 indexed citations

Shou, Magang, Grit Sandig, Ping Lu, et al.. (2003). SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450. Drug Metabolism and Disposition. 31(9). 1161–1169. 64 indexed citations

Rushmore, Thomas H., et al.. (2002). Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes. Current Drug Metabolism. 3(5). 481–490. 334 indexed citations

Qin, Mei, Cuyue Tang, Yuh J. Lin, Thomas H. Rushmore, & Magang Shou. (2002). Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450. Drug Metabolism and Disposition. 30(6). 701–708. 10 indexed citations

10.

Shou, Magang, Renke Dai, Dan Cui, et al.. (2001). A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4. Journal of Biological Chemistry. 276(3). 2256–2262. 101 indexed citations

11.

Rushmore, Thomas H., et al.. (2000). Bioreactor Systems in Drug Metabolism: Synthesis of Cytochrome P450-Generated Metabolites. Metabolic Engineering. 2(2). 115–125. 56 indexed citations

12.

Gerhold, David, Thomas H. Rushmore, & C. Thomas Caskey. (1999). DNA chips: promising toys have become powerful tools. Trends in Biochemical Sciences. 24(5). 168–173. 199 indexed citations

13.

Haining, Robert L., Kirk R. Henne, George Davis, et al.. (1997). Genetic association between sensitivity to warfarin and expression of CYP2C9*3. Pharmacogenetics. 7(5). 361–367. 239 indexed citations

14.

Fei, Peiwen, George A. Matwyshyn, Thomas H. Rushmore, & Ah‐Ng Tony Kong. (1996). Transcription Regulation of Rat Glutathione S-Transferase Ya Subunit Gene Expression by Chemopreventive Agents. Pharmaceutical Research. 13(7). 1043–1048. 14 indexed citations

15.

Cribb, Alastair E., et al.. (1994). Increased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.. Drug Metabolism and Disposition. 22(6). 969–972. 1 indexed citations

16.

Rushmore, Thomas H. & C B Pickett. (1991). Characterization of the antioxidant responsive element (ARE): A xenobiotic responsive element controlling expression of the rat glutathione S-transferase Ya subunit gene by phenolic antioxidants. 1 indexed citations

17.

Rushmore, Thomas H. & Cecil B. Pickett. (1991). [39] Xenobiotic responsive elements controlling inducible expression by planar aromatic compounds and phenolic antioxidants. Methods in enzymology on CD-ROM/Methods in enzymology. 206. 409–420. 22 indexed citations

18.

Best, Susan J., et al.. (1990). Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Toxicology and Applied Pharmacology. 105(3). 351–363. 49 indexed citations

19.

Ghoshal, Amit, et al.. (1988). Glutathione and enzymes related to free radical metabolism in liver of rats fed a choline-devoid low-methionine diet. Cancer Letters. 41(1). 53–62. 7 indexed citations

20.

Semple, E., M A Hayes, Thomas H. Rushmore, Leonard Harris, & Emmanuel Farber. (1987). Mitogenic activity in platelet-poor plasma from rats with persistent liver nodules or liver cancer. Biochemical and Biophysical Research Communications. 148(1). 449–455. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact